4.6 Article

Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study

Related references

Note: Only part of the references are listed.
Letter Pharmacology & Pharmacy

Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease

Larry Baum et al.

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2008)

Article Pharmacology & Pharmacy

Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer's disease

Aynun N. Begum et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)

Article Biochemical Research Methods

Suppression of murine cerebral F2-isoprostanes and F4-neuroprostanes from excitotoxicity and innate immune response in vivo by α- or γ-tocopherol

D Milatovic et al.

JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2005)

Article Neurosciences

Curcumin has potent anti-amyloidogenic effects for Alzheimer's β-amyloid fibrils in vitro

K Ono et al.

JOURNAL OF NEUROSCIENCE RESEARCH (2004)

Article Biochemical Research Methods

Curcumin in plasma and urine: quantitation by high-performance liquid chromatography

DD Heath et al.

JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2003)

Article Geriatrics & Gerontology

Phenolic anti-inflammatory antioxidant reversal of Aβ-induced cognitive deficits and neuropathology

SA Frautschy et al.

NEUROBIOLOGY OF AGING (2001)

Review Geriatrics & Gerontology

Inflammation and Alzheimer's disease

H Akiyama et al.

NEUROBIOLOGY OF AGING (2000)